Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Combination of drugs might decrease the chance of chronic myeloid leukemia returning

Combination of drugs might decrease the chance of chronic myeloid leukemia returning

Detection of gene fusions in prostate cancer

Detection of gene fusions in prostate cancer

Dasatinib shows promise as first treatment for chronic myelogenous leukemia

Dasatinib shows promise as first treatment for chronic myelogenous leukemia

Unstable leukemia stem cells may predispose patients to drug resistance

Unstable leukemia stem cells may predispose patients to drug resistance

Discovery of new cell involved with cancer

Discovery of new cell involved with cancer

New drug to combat Gastrointestinal graft-vs.-host disease in stem-cell patients shows significant reduction in deaths

New drug to combat Gastrointestinal graft-vs.-host disease in stem-cell patients shows significant reduction in deaths

Nanoparticle encapsulation improves bioavailability of leukemia drug

Nanoparticle encapsulation improves bioavailability of leukemia drug

UIC receives $20 million NCI grant to research blood disorders

UIC receives $20 million NCI grant to research blood disorders

Turning the immune system against cancer

Turning the immune system against cancer

Smart cancer drug on sale in the UK

Smart cancer drug on sale in the UK

Gleevec may cause heart problems

Gleevec may cause heart problems

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib)

New leukemia drug gives renewed hope to those battling drug resistance to the disease

New leukemia drug gives renewed hope to those battling drug resistance to the disease

Dasatinib offers new options for leukemia patients

Dasatinib offers new options for leukemia patients

Gleevec strangles drug-resistant, metastatic prostate cancer

Gleevec strangles drug-resistant, metastatic prostate cancer

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Cancer treatment interferes with bone development

Cancer treatment interferes with bone development

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Finding indicate why some kinds of Leukemia are more aggressive than others

Finding indicate why some kinds of Leukemia are more aggressive than others

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.